Prostate Cancer Clinical Trial

Vaccine Study of MVA-MUC1-IL2 in Patients With Prostate Cancer

Summary

This study involves the use of an experimental product, TG4010. The purpose of the study is to determine if TG4010 can stimulate the body's immune system to help it fight the cancer.

View Full Description

Full Description

The experimental product, TG4010, is a modified vaccinia virus (already used in humans) into which two (2) genes have been placed. One gene is for a protein (MUC1) found in cancer cells. The second gene is for human interleukin 2 (IL2) which the body's immune system makes to help it fight cancer. The TG4010 is given as an injection under the skin (subcutaneous) once a week for six weeks followed by a schedule of every three weeks or every three weeks for the first twelve (12) weeks. If the therapy is working, it can be continued for up to 9 months until no further improvement or until the patient gets worse for as long as it is tolerated.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Rising PSA after surgery or radiation for prostate cancer

Exclusion Criteria:

Metastasis or local disease
Prior hormone treatment

Study is for people with:

Prostate Cancer

Phase:

Phase 2

Estimated Enrollment:

50

Study ID:

NCT00040170

Recruitment Status:

Terminated

Sponsor:

Transgene

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 3 Locations for this study

See Locations Near You

Arizona Cancer Center
Tucson Arizona, 85724, United States
UCLA
Los Angeles California, 90095, United States
Cleveland Clinic Foundation
Cleveland Ohio, 44195, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Phase:

Phase 2

Estimated Enrollment:

50

Study ID:

NCT00040170

Recruitment Status:

Terminated

Sponsor:


Transgene

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider